Scotia Capital’s Parexel International Corp PRXL Stock Holding History
Bought
Maintained
Sold
Other funds holding PRXL
CS
AAM
Scotia Capital's PRXL Position: Q1 2017 in Review
Scotia Capital sold out of Parexel International Corp (PRXL) in Q1 2017, closing a stake of 3,950 shares — an estimated $260K sold.
Scotia Capital first reported a position in PRXL in Q3 2014 and held it in 9 quarters. The position peaked at $511K in Q4 2015. 308 funds tracked by Wall St. Rank hold PRXL as of Q1 2017.
- Scotia Capital reported no remaining Parexel International Corp position as of Q1 2017 after selling out during the quarter.
- Scotia Capital sold 3,950 Parexel International Corp shares in Q1 2017, an estimated $260K.
- Scotia Capital first reported a position in Parexel International Corp in Q3 2014 and held it in 9 quarters.
- Scotia Capital's Parexel International Corp position peaked at $511K in Q4 2015.
- 308 funds tracked by Wall St. Rank held Parexel International Corp as of Q1 2017.
Based on Scotia Capital's 13F filing for Q1 2017, filed 15 May 2017.